TITLE

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial of Tafenoquine for Weekly Prophylaxis against Plasmodium falciparum

AUTHOR(S)
Hale, Branden R.; Owusu-Agyei, Seth; Fryauff, David J.; Koram, Kwadwo A.; Adjuik, Martin; Oduro, Abraham R.; Prescott, W. Roy; Baird, J. Kevin; Nkrumah, Francis; Ritchie, Thomas L.; Franke, Eileen D.; Binka, Fred N.; Horton, John; Hoffman, Stephen L.
PUB. DATE
March 2003
SOURCE
Clinical Infectious Diseases;3/1/2003, Vol. 36 Issue 5, p541
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Tafenoquine is a promising new 8-aminoquinoline drug that may be useful for malaria prophylaxis in non-pregnant persons with normal glucose-6-phosphate dehydrogenase (G6PD) function. A randomized, double-blind, placebo-controlled chemoprophylaxis trial was conducted with adult residents of northern Ghana to determine the minimum effective weekly dose of tafenoquine for the prevention of infection by Plasmodium falciparum. The primary end point was a positive malaria blood smear result during the 13 weeks of study drug coverage. Relative to the placebo, all 4 tafenoquine dosages demonstrated significant protection against P. falciparum infection: for 25 mg/week, protective efficacy was 32% (95% confidence interval [CI], 20%-43%); for 50 mg/week, 84% (95% CI, 75%-91%); for 100 mg/week, 87% (95% CI, 78%-93%); and for 200 mg/week, 86% (95% CI, 76%-92%). The mefloquine dosage of 250 mg/week also demonstrated significant protection against P. falciparum infection (protective efficacy, 86%; 95% CI, 72%-93%). There was little difference between study groups in the adverse events reported, and there was no evidence of a relationship between tafenoquine dosage and reports of physical complaints or the occurrence of abnormal laboratory parameters. Tafenoquine dosages of 50, 100, and 200 mg/week were safe, well tolerated, and effective against P. falciparum infection in this study population.
ACCESSION #
9424759

 

Related Articles

  • Comparative performance of the ParaSight F test for detection of Plasmodium falciparum in malaria... Fryauff, D.J.; Gomez-Saladin, E.; Purnomo; Sumawinata, I.; Sutamihardja, M.A.; Tuti, S.; Subianto, B.; Richie, T.L. // Bulletin of the World Health Organization;1997, Vol. 75 Issue 6, p547 

    Compares the performance of the ParaSight F test for the detection of Plasmodium falciparum in blood from malaria-immune and nonimmune populations in Irian Jaya, Indonesia. Information pertaining to test; Where differences were seen; Method and results of the study conducted.

  • Protection of Humans against Malaria by Immunization with Radiation-Attenuated Plasmodium falciparum Sporozoites. Hoffman, Stephen L.; Goh, Lucy M.L.; Luke, Thomas C.; Schneider, Imogene; Le, Thong P.; Doolan, Denise L.; Sacci, John; de la Vega, Patricia; Dowler, Megan; Paul, Chris; Gordon, Daniel M.; Stoute, Jose A.; Church, L.W. Preston; Sedegah, Martha; Heppner, D. Gray; Ballou, W.Ripley; Richie, Thomas L. // Journal of Infectious Diseases;4/15/2002, Vol. 185 Issue 8, p1155 

    During 1989-1999, 11 volunteers were immunized by the bites of 1001-2927 irradiated mosquitoes harboring infectious sporozoites of Plasmodium falciparum (Pf) strain NF54 or clone 3D7/NF54. Ten volunteers were first challenged by the bites of Pf-infected mosquitoes 2-9 weeks after the last...

  • Control of malaria: a successful experience from Viet Nam. Hung, Le Q.; de Vries, Peter J.; Giao, Phan T.; Nam, Nguyen V.; Binh, Tran Q.; Chong, M.T.; Quoc, N.T.T.A.; Thanh, T.N.; Hung, L.N.; Kager, P.A. // Bulletin of the World Health Organization;2002, Vol. 80 Issue 8, p660 

    Objective To follow malaria prospectively in an ethnic minority commune in the south of Viet Nam with high malaria transmission and seasonal fluctuation, during malaria control interventions using insecticide-treated bednets (ITBNs) and early diagnosis and treatment (EDT) of symptomatic...

  • Treatment uptake by individuals infected with Plasmodium falciparumin rural Gambia, West Africa. von Seidlein, Lorenz; Clarke, Siân; Alexander, Neal; Manneh, Fandingding; Doherty, Tom; Pinder, Margaret; Walraven, Gijs; Greenwood, Brain // Bulletin of the World Health Organization;2002, Vol. 80 Issue 10, p790 

    To find out what proportion of Plasmodium falciparum infections are treated in rural Gambia. Subjects from four villages in the Gambia were followed over nine months through visits to village health workers. Monthly cross-sectional malaria surveys measured the prevalence of P. falciparum...

  • Jarisch-Herxheimer reaction in falciparum malaria? Kofoed, Poal Erik // British Medical Journal (Clinical Research Edition);7/21/1984, Vol. 289 Issue 6438, p161 

    Details a case study of Jarisch-Herxheimer reaction in falciparum malaria in Denmark. Symptoms of patient infected with Plasmodium falciparum; Treatment of malaria; Features of Jarisch-Herxheimer reaction.

  • Dose-Finding Study of the Efficacy of Fixed-Combination Artemether/Lumefantrine for the Treatment of Multidrug-Resistant Plasmodium falciparum Malaria in Thailand. Karbwang, J.; Na-Bangchang, K.; Thanavibul, A.; Mull, R.; Gathmann, I. // Clinical Drug Investigation;2000, Vol. 19 Issue 5, p343 

    Objective: To investigate the efficacy and tolerability of three different regimens of the fixed combination artemether/lumefantrine (artemether/benflumetol) in patients with multidrug-resistant Plasmodium falciparum malaria. Design: Randomised, double-blind, dose-finding study. Setting: Two...

  • Failure of Doxycycline as a Causal Prophylactic Agent against Plasmodium falciparum Malaria in Healthy Nonimmune Volunteers. Shmuklarsky, Moshe J.; Boudreau, Ellen F.; Pang, Lorrin W.; Smith, Joseph I.; Schneider, Imogene; Fleckenstein, Lawrence; Abdelrahim, Maged M.; Canfield, Craig J.; Schuster, Brian // Annals of Internal Medicine;2/15/94, Vol. 120 Issue 4, p294 

    Objective: To determine whether doxycycline, 100 mg administered as a single daily oral dose, is effective as a causal prophylactic agent, an agent active against the pre-erythrocytic liver stage of Plasmodium falciparum malaria parasites, in healthy nonimmune persons. If effective, the...

  • Malaria Reemergence in the Peruvian Amazon Region. Aramburu Guarda, Javier; Ramal Asayag, Cesar; Witzig, Richard // Emerging Infectious Diseases;Mar/Apr99, Vol. 5 Issue 2, p209 

    Reports the reemergence of Plasmodium falciparum infection in the Peruvian Amazon Region after the eradication efforts of the 1960s. Epidemiology; Vector dynamics of malaria; Climatic associations on the occurrence of malaria.

  • Genomics: Malaria – the enemy's battle plan. Gunter, Chris // Nature Reviews Genetics;Nov2002, Vol. 3 Issue 11, p820 

    Unveils the sequences of two species of the human malarial parasite Plasmodium falciparum. Estimated number of genes identified in Plasmodium falciparum; Apicoplast metabolic pathways that must be investigated further for antimalarials.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics